Developer docs
API playgroundTry for free, no card

Search company profiles

Woven Science

Full company profile

uuid0002ej9

Namestring
Woven Science
Legal namestring
Woven Science
Websiteurl
woven.science
Company typeenum
Private
Founded yearint
2021
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
psychedelic therapeutics investing, mental wellness ventures, drug development incubation, health technology investment, plant-medicine distribution
Industry5 codes
PRIMARYEDAAAHAK
Mental Wellness & Resilience Education (Non-clinical)
Education/Adult & Continuing Education/Health, Wellness & Lifestyle Education (Nutrition, Fitness, Mindfulness)
SECONDARYHSADAJAH
Meditation Apps, Digital Courses & Online Communities
SECONDARYCRADAGAM
Healthy Aging & Cognitive Support Supplements
SECONDARYAFAFAFAF
Botanical/Herbal & Adaptogen Functional Beverage Production
Agriculture & Food Production/Beverage Production/Functional & Nutritional Beverage Production (Energy, Sports, Fortified)
SECONDARYEDAAAHAD
Mindfulness, Meditation & Stress Management Education
Education/Adult & Continuing Education/Health, Wellness & Lifestyle Education (Nutrition, Fitness, Mindfulness)
NAICS code3 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Professional, Scientific, and Technical Services541
  • Medicinal and Botanical Manufacturing325411
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Medicinal Chemicals & Botanical Products2833
Product category
Psychedelic Wellness Investment
Social media profiles1 record
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 3 records shown
1Woven Labs
Description

Supporting mission-adjacent companies in drug development, delivery and health technology investment, incubation, and acceleration.

woven.science
+2 more records
Core offering1 text field

Woven Science backs and builds psychedelic and wellness companies through three integrated pillars: Woven Labs (drug development, health technology investment, and an accelerator/incubation program), Woven Wellness (plant-medicine and wellbeing product development and distribution), and El Puente (a foundation plus DAO that dedicates 10% of company equity to indigenous benefit-sharing through grants, education, regeneration, and sovereignty initiatives). The company invests in and operates portfolio companies that address unmet needs across the mental health treatment arc.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Woven Science is a psychedelic and wellness investment and development company operating as a unified platform built on three core pillars: Woven Labs (drug development, health technology investment, incubation, and acceleration), Woven Wellness (plant-medicine and wellbeing product development and distribution), and El Puente (indigenous benefit-sharing and reciprocity initiative). The company backs and builds leading psychedelic and wellness companies, targeting unmet needs across every stage of the treatment arc.

Product and service4 records
1Woven Labs
CategoryVenture incubation and accelerator
Description

Investment and incubation arm of Woven Science that supports mission-adjacent companies in drug development, delivery, and health technology through equity investment and an accelerator program, intended for founders of psychedelic and wellness companies seeking capital and operational support.

2Woven Wellness
CategoryWellness product development
Description

Plant-medicine and wellbeing product development and distribution division of Woven Science, creating consumer wellness offerings within the company's psychedelic care platform.

3El Puente
CategoryFoundation and grant-making
Description

Foundation initiative of Woven Science that allocates 10% of company equity to facilitate grants and investments into indigenous-owned projects across four pillars: reciprocity, education, regeneration, and sovereignty, governed by a council of indigenous leaders with vote and veto powers.

4El Puente DAO
CategoryCommunity DAO
Description

Decentralized autonomous organization associated with the El Puente initiative, providing a community-based platform to engage members in access and benefit-sharing for indigenous communities in the psychedelic sector.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-05-21
Description

Woven Science co-led an investment in a Swiss drug development firm as part of their portfolio strategy across multiple countries.

2MCKA (Multicultural Cannabis Knowledge Alliance)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Beneficiary of El Puente foundation grants and investments, focusing on indigenous capacity building and knowledge sharing.

woven.science
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Beneficiary of El Puente foundation, involved in regeneration and ecosystem protection initiatives.

4BGD
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Beneficiary of El Puente foundation grants supporting indigenous-owned projects.

woven.science
5Kene Rao
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Beneficiary of El Puente foundation focusing on indigenous capacity building.

woven.science
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Beneficiary of El Puente foundation grants and investments.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Beneficiary of El Puente foundation, involved in education and preservation initiatives in psychedelics sector.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Public clinical-stage psychedelic medicine company developing psilocybin therapy for treatment-resistant depression. Direct peer because both are building portfolios/platforms around psychedelic-assisted mental health treatment, though Compass is focused on a single clinical asset.

2Atai Life Sciences
TypeDirect peer
Description

Public clinical-stage platform company developing psychedelic and non-psychedelic compounds for mental health. Closely comparable venture-platform model with multiple portfolio companies, drug development focus, and mental wellness thesis.

3MindMed
TypeDirect peer
Description

Public psychedelic medicine company developing psychedelic-inspired and psychedelic-derived therapies. Direct competitor in the psychedelic therapeutics space with overlapping drug development pipeline and mental health focus.

TypeDirect peer
Description

Public psychedelic therapeutics company developing psilocybin-based treatments for depression and addiction. Direct peer sharing Woven's psychedelic drug development and mental wellness mission.

TypeDirect peer
Description

Private psychedelic medicine company developing psilocybin and DMT-based therapies. Comparable as a psychedelic-focused drug development company targeting mental health indications.

6Field Trip Health
TypeDirect peer
Description

Operator of psychedelic-assisted therapy clinics and developer of psilocybin-based treatments. Direct peer in Woven's clinic and treatment-arc coverage, though Field Trip exited clinic operations in 2023.

TypeDirect peer
Description

Public clinical-stage company developing DMT-based therapies for treatment-resistant depression. Direct peer in psychedelic drug development for mental health, though focused on a single compound (DMT).

TypeBroad incumbent
Description

Long-standing nonprofit research organization that has driven much of the modern psychedelic therapy field, including MDMA-assisted therapy for PTSD. Comparable as a broader force shaping the psychedelic sector Woven is building into.

TypeOthers
Description

Specialized venture fund focused on psychedelic medicine and mental health companies; led Woven Science's seed round. Investor and ecosystem enabler rather than direct competitor, but highly comparable as a psychedelic-focused capital platform.

TypeEmerging player
Description

Public psychedelic wellness company developing psilocybin products and retreat experiences. Emerging peer in the wellness/plant-medicine portion of Woven's platform, though with narrower scope.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Woven Science

Psychedelic Wellness Investmentwoven.science

Woven Science firmographics

Firmographics
Name
Woven Science
Legal name
Woven Science
Website
https://woven.science
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

Woven Science industry classification

Industry
Product category
Psychedelic Wellness Investment
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Professional, Scientific, and Technical Services (541), Medicinal and Botanical Manufacturing (325411)
SIC
Services-Commercial Physical & Biological Research (8731), Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYEDAAAHAK
Mental Wellness & Resilience Education (Non-clinical)
Education/Adult & Continuing Education/Health, Wellness & Lifestyle Education (Nutrition, Fitness, Mindfulness)
SECONDARYHSADAJAH
Meditation Apps, Digital Courses & Online Communities
SECONDARYCRADAGAM
Healthy Aging & Cognitive Support Supplements
SECONDARYAFAFAFAF
Botanical/Herbal & Adaptogen Functional Beverage Production
Agriculture & Food Production/Beverage Production/Functional & Nutritional Beverage Production (Energy, Sports, Fortified)
SECONDARYEDAAAHAD
Mindfulness, Meditation & Stress Management Education
Education/Adult & Continuing Education/Health, Wellness & Lifestyle Education (Nutrition, Fitness, Mindfulness)

Keywords

  • Psychedelic therapeutics investing
  • Mental wellness ventures
  • Drug development incubation
  • Health technology investment
  • Plant-medicine distribution

Where Woven Science is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Woven Science business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Distribution channels1 record

Marketing channels3 records

Woven Science product offering

Product offering

Core offering

Woven Science backs and builds psychedelic and wellness companies through three integrated pillars: Woven Labs (drug development, health technology investment, and an accelerator/incubation program), Woven Wellness (plant-medicine and wellbeing product development and distribution), and El Puente (a foundation plus DAO that dedicates 10% of company equity to indigenous benefit-sharing through grants, education, regeneration, and sovereignty initiatives). The company invests in and operates portfolio companies that address unmet needs across the mental health treatment arc.

Product overview

Woven Science is a psychedelic and wellness investment and development company operating as a unified platform built on three core pillars: Woven Labs (drug development, health technology investment, incubation, and acceleration), Woven Wellness (plant-medicine and wellbeing product development and distribution), and El Puente (indigenous benefit-sharing and reciprocity initiative). The company backs and builds leading psychedelic and wellness companies, targeting unmet needs across every stage of the treatment arc.

Differentiator

Problem solved

Functional benefit

Brands

  • Woven Labs: Supporting mission-adjacent companies in drug development, delivery and health technology investment, incubation, and acceleration.
  • Woven Wellness
  • El Puente

Products and services

  • Woven Labs Investment and incubation arm of Woven Science that supports mission-adjacent companies in drug development, delivery, and health technology through equity investment and an accelerator program, intended for founders of psychedelic and wellness companies seeking capital and operational support.
  • Woven Wellness Plant-medicine and wellbeing product development and distribution division of Woven Science, creating consumer wellness offerings within the company's psychedelic care platform.
  • El Puente Foundation initiative of Woven Science that allocates 10% of company equity to facilitate grants and investments into indigenous-owned projects across four pillars: reciprocity, education, regeneration, and sovereignty, governed by a council of indigenous leaders with vote and veto powers.
  • El Puente DAO Decentralized autonomous organization associated with the El Puente initiative, providing a community-based platform to engage members in access and benefit-sharing for indigenous communities in the psychedelic sector.

Companies that use Woven Science

Customer profile

Segments2 records

Ideal customer profiles2 records

Woven Science technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Woven Science partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered minor and core.

  • Swiss drug development firm (unnamed)minorStrategic or Co-development Partner · 21 May 2021Woven Science co-led an investment in a Swiss drug development firm as part of their portfolio strategy across multiple countries.
  • MCKA (Multicultural Cannabis Knowledge Alliance)coreStrategic or Co-development PartnerBeneficiary of El Puente foundation grants and investments, focusing on indigenous capacity building and knowledge sharing.
  • RSF (Rainforest Seed)coreStrategic or Co-development PartnerBeneficiary of El Puente foundation, involved in regeneration and ecosystem protection initiatives.
  • BGDcoreStrategic or Co-development PartnerBeneficiary of El Puente foundation grants supporting indigenous-owned projects.
  • Kene RaocoreStrategic or Co-development PartnerBeneficiary of El Puente foundation focusing on indigenous capacity building.
  • The FountaincoreStrategic or Co-development PartnerBeneficiary of El Puente foundation grants and investments.
  • ICEERS (International Center for Ethnobotanical Education, Research and Service)coreStrategic or Co-development PartnerBeneficiary of El Puente foundation, involved in education and preservation initiatives in psychedelics sector.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Woven Science competitors and assessment

Company assessment

Direct peers

  • Compass Pathways: Public clinical-stage psychedelic medicine company developing psilocybin therapy for treatment-resistant depression. Direct peer because both are building portfolios/platforms around psychedelic-assisted mental health treatment, though Compass is focused on a single clinical asset.
  • Atai Life Sciences: Public clinical-stage platform company developing psychedelic and non-psychedelic compounds for mental health. Closely comparable venture-platform model with multiple portfolio companies, drug development focus, and mental wellness thesis.
  • MindMed: Public psychedelic medicine company developing psychedelic-inspired and psychedelic-derived therapies. Direct competitor in the psychedelic therapeutics space with overlapping drug development pipeline and mental health focus.
  • Cybin: Public psychedelic therapeutics company developing psilocybin-based treatments for depression and addiction. Direct peer sharing Woven's psychedelic drug development and mental wellness mission.
  • Beckley Psytech: Private psychedelic medicine company developing psilocybin and DMT-based therapies. Comparable as a psychedelic-focused drug development company targeting mental health indications.
  • Field Trip Health: Operator of psychedelic-assisted therapy clinics and developer of psilocybin-based treatments. Direct peer in Woven's clinic and treatment-arc coverage, though Field Trip exited clinic operations in 2023.
  • GH Research: Public clinical-stage company developing DMT-based therapies for treatment-resistant depression. Direct peer in psychedelic drug development for mental health, though focused on a single compound (DMT).

Broad incumbents

Others

  • Noetic Fund: Specialized venture fund focused on psychedelic medicine and mental health companies; led Woven Science's seed round. Investor and ecosystem enabler rather than direct competitor, but highly comparable as a psychedelic-focused capital platform.

Emerging players

  • Silo Wellness: Public psychedelic wellness company developing psilocybin products and retreat experiences. Emerging peer in the wellness/plant-medicine portion of Woven's platform, though with narrower scope.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Woven Science social profiles

Digital presence

Woven Science financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Woven Science leadership team

Management profile

Number of profiles

Profiles8 records

Woven Science funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Woven Science M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Woven Science

What does Woven Science do?

Woven Science backs and builds psychedelic and wellness companies through three integrated pillars: Woven Labs (drug development, health technology investment, and an accelerator/incubation program), Woven Wellness (plant-medicine and wellbeing product development and distribution), and El Puente (a foundation plus DAO that dedicates 10% of company equity to indigenous benefit-sharing through grants, education, regeneration, and sovereignty initiatives). The company invests in and operates portfolio companies that address unmet needs across the mental health treatment arc.

Is Woven Science a public or private company?

Woven Science is a private company. It is classified as venture growth investor backed and is currently operating.

When was Woven Science founded?

Woven Science was founded in 2021. It employs 1 to 10 people.

Where is Woven Science based?

Woven Science is headquartered in New York, United States, in the North America region.

Who are Woven Science's main competitors?

Direct peers on record are Compass Pathways, Atai Life Sciences, MindMed, Cybin, Beckley Psytech, Field Trip Health and GH Research. MAPS (Multidisciplinary Association for Psychedelic Studies) is listed as a broad incumbent. Noetic Fund is listed as an others. Silo Wellness is listed as an emerging player.

Does Woven Science have an API?

No public API is recorded for Woven Science.

What industry is Woven Science in?

Woven Science's product category is Psychedelic Wellness Investment. Its primary akta.pro industry code is EDAAAHAK, Mental Wellness & Resilience Education (Non-clinical), with a secondary code of HSADAJAH, Meditation Apps, Digital Courses & Online Communities. Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswirePeople Science™ and Woven Science Partner to Test Natural and Psychedelic Medicines.People Science and Woven Science announced a partnership to test alternative and psychedelic medicines using People Science's virtual clinical trial platform, CHLOE. The collaboration will launch its first study evaluating a cannabinoid product for sleep, allowing participants to enroll and provide data remotely from home. This initiative aims to revolutionize clinical validation for alternative medicines by leveraging technology-driven, consumer-centered research methods.ForbesAccelerator For ‘Psychedelic-Adjacent’ Startups Is Part Of Holding Company StrategyWoven Science and Founders Factory launched a six-month accelerator for psychedelic-adjacent startups, offering $75,000 in funding and bespoke mentoring. The program targets health tech, consumer goods, and telemedicine, with equity stakes of 4-7% typically, though Satori Health received 25%.GlobeNewswireWoven Science's El Puente Releases Its Policy Paper on Indigenous Reciprocity & Corporate Social ResponsibilityWoven Science's El Puente foundation released a policy paper and CSR initiative for psychedelic companies to engage with indigenous peoples. The paper proposes four policy solutions, including bio-cultural conservation, appellations of origin, regulatory sandboxes, and financial sharing. A 45-day public comment period is open.Business InsiderA startup accelerator that's worked with J&J and L'Oréal is getting into psychedelics as the industry goes mainstreamFounders Factory, an accelerator that has worked with L'Oréal and Johnson & Johnson, is launching a psychedelics program with Woven Science. Startups will receive $75,000 in funding and mentorship over four to six months, targeting a market estimated at $100 billion. The program expects about 10 companies to join over two years.YahooWoven Science Launches Psychedelic Care Platform with Oversubscribed $8.5M Seed FinancingWoven Science launched a psychedelic care platform and secured an oversubscribed $8.5M seed financing round to build its operations across compounds, clinics, and community support. The company is expanding its portfolio through investments like a co-led $4.1M round in Swiss firm Reconnect Labs AG and partnerships with therapists in Portland, Oregon. This strategic move aims to integrate psychedelic therapies with long-term wellness practices supported by its subsidiary, The Fifth Kingdom.BioSpaceWoven Science Launches Psychedelic Care Platform with Oversubscribed $8.5M Seed FinancingWoven Science launched a psychedelic care platform and secured an oversubscribed $8.5 million seed financing round to build its operational pillars of compounds, clinics, and community. The company is expanding its reach across the US, Canada, Switzerland, and the UK, having recently co-led a $4.1 million investment in Swiss drug developer Reconnect Labs AG. This funding supports the development of therapeutic assets and partnerships with therapists to offer psychedelic-assisted therapies.